# Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer

> **NCT00687297** · PHASE2 · COMPLETED · sponsor: **PrECOG, LLC.** · enrollment: 162 (actual)

## Conditions studied

- Lung Cancer
- Non Small Cell Lung Cancer

## Interventions

- **DRUG:** vandetanib induction
- **DRUG:** Docetaxel
- **DRUG:** Carboplatin
- **DRUG:** Placebo
- **DRUG:** Vandetanib maintenance

## Key facts

- **NCT ID:** NCT00687297
- **Lead sponsor:** PrECOG, LLC.
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-04
- **Primary completion:** 2011-01
- **Final completion:** 2011-04
- **Target enrollment:** 162 (ACTUAL)
- **Last updated:** 2018-05-30

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00687297

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00687297, "Study of Vandetanib Combined With Chemotherapy to Treat Advanced Non-small Cell Lung Cancer". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT00687297. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*